24-25 September 1997
AGENDA
9:00-9:15 Welcome and opening
9:15-10:00 Scientific Overview
Difference between somatic therapy and germ-line interventions; current gene transfer capabilities; status of scientific experiments with animals; promising future directions.
Speaker: Theodore Friedmann, M.D., University of California, San Diego
10:00-11:15 Clinical Applications
Results of clinical experiments; strategies for medical applications; prospects for therapeutic applications; enhancement capabilities.
Speaker: Malcolm Brenner, M.D., St. Jude's Hospital, Memphis>
11:15-11:30 Break
11:30-1:00 Scientific freedom and responsibility issues
Consideration of acceptable levels of risk in human germ-line experiments; criteria for determining appropriateness of human research; public policy status in other countries; scientific vs. governmental regulation; promoting public dialogue on human germ-line interventions.
Panelists:
Pilar Ossorio, Ph.D., J.D., American Medical Association; Malcolm Brenner, M.D., St. Jude's Hospital, Memphis; Cynthia Cohen, Ph.D., J.D., Georgetown University; Lee Silver, Ph.D., Princeton University
1:00-2:30 Lunch (on your own)
2:30-3:00 Presentation on the history and status of religious involvement
Speaker: Roger Shinn, Ph.D., Union Theological Seminary, Columbia University
3:00-5:00 Ethical and theological issues
Is germ-line alteration "playing God?"; would germ-line modifications contradict responsibilities to future generations; what kinds of justice concerns are involved; differences in perspective among various religious communities.
Panelists: Moshe Tendler, Ph.D., Yeshiva University (New York); Abdulaziz Sachedina, Ph.D., University of Virginia, Charlottesville; Ron Cole-Turner, Ph.D., Pittsburgh Theological Seminary; Albert Moraczewski, Ph.D., Pope John Paul Center for the Study of Ethics in Health Care
5:00-6:30 Dinner (on your own)
6:30-8:30 Therapeutic vs. enhancement applications
Difference between therapeutic and enhancement applications; rationale and cautions for therapeutic interventions; eugenic implications.
Speaker: Eric Juengst, Ph.D., Case Western Reserve University
Respondents: Erik Parens, Ph.D., The Hastings Center; Robert Murray, M.D., Howard University (invited)
September 25
9:00-12:00 Setting policy and developing guidelines on human germ-line research and applications
Models of policy setting; public policy in other countries; appropriateness of the National Bioethics Advisory Commission process; how best to proceed.
Speaker: Tom Murray, Ph.D., Case Western Reserve University; Leroy Walters, Ph.D., Georgetown University (invited)
Respondents: Theodore Friedmann, M.D. (invited), Univ. of California, San Diego; Gladys White, R.N., Ph.D., National Advisory Board on Ethics and Reproduction
|
